Second Genome

Insitro is a pioneering drug company based in South San Francisco, California, that is revolutionizing the development of medicines through the power of machine learning and data analysis. By decoding the complexities of biology, they aim to bring better drugs to patients faster, focusing on therapeutic programs in metabolism, oncology, and neuroscience. With a robust machine learning platform fueled by extensive data, Insitro integrates in vitro cellular data with human clinical data to redefine disease and identify therapeutic insights and interventions across a wide range of diseases. Their unique culture unites individuals from diverse backgrounds, including life scientists, data scientists, engineers, and drug hunters, who collaborate to generate scientific breakthroughs in drug discovery and development.Generated from the website